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Abstract
Background: Zfx is a zinc finger protein of the Zfy family, whose members are highly conserved in vertebrates. Zfx
is a shared transcriptional regulator of both embryonic stem cells (ESC) and hematopoietic stem cells (HSC), which
suggests a common genetic basis of self-renewal in embryonic and adult stem cells. The level of Zfx expression
correlates with aggressiveness and severity in many cancer types, including prostate cancer, breast cancer, and
leukemia. However, the importance of Zfx in human glioma is largely unknown. In the present study, we examined
the role of Zfx in human glioma.
Methods: We detected expression levels of Zfx mRNA in U251 cells, U87 cells, U373 cells, and A172 cells by semi-
quantitative RT-PCR. To analyze the expression of Zfx mRNA in glioma tissues, we performed real-time quantitative
PCR on 35 pathologically confirmed glioma samples (Grade I-4cases, Grade II-13cases, Grade III-11cases, and Grade
IV-7cases) and on 5 noncancerous brain tissue samples. We used lentivirus-mediated small interfering RNAs
(siRNAs) to knock down Zfx expression in the human malignant glioma cell line U251. Changes in Zfx target gene
expression were determined by real-time RT-PCR. Cell proliferation was examined by a High Content Screening
assay. DNA synthesis in proliferating cells was determined by BrdU incorporation. Cell cycle distribution and
apoptosis were detected by flowcytometric analysis.
Results: We discovered that Zfx mRNA was expressed in U251 cells, U87 cells, U373 cells, and A172 cells. The
expression level of Zfx is significantly higher in gliomas compared to noncancerous brain tissue. Using a lentivirus-
based RNAi approach, Zfx expression was significantly inhibited in human glioblastoma U251 cells. The effects of
Zfx knockdown on cell proliferation, cell cycle distribution, and apoptosis were assessed. Inhibition of Zfx
expression in U251 cells by RNAi significantly impaired cell proliferation, increased apoptosis, and arrested cells in S
phase.
Conclusions: The results of our study demonstrate that the Zfx gene is highly expressed in glioma tissue and in
glioma cell lines. Furthermore, Zfx may play a critical role in cell proliferation, cell cycle distribution, and apoptosis
of human malignant glioma cells.
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Malignant glioma is one of the most common and fatal
types of brain tumors in humans [1]. It is the second
major cause of cancer-related deaths in both children
and young adults, and it is the second fastest growing
cause of cancer deaths among those over 65 years old
[2-4]. Even when treated with surgery, radiation, and
chemotherapy, the median life expectancy of brain can-
cer patients is only 12-14 months [5,6]. Despite signifi-
cant gains in the understanding of glioblastoma biology,
the prognosis of the disease has not significantly chan-
ged over the last 20 years.
The Zfx gene is located on the mammalian X chromo-
some, at Xp22.12, approximately 23 Mb proximal to this
boundary. Zfx is a zinc finger transcription factor that is
highly conserved among vertebrates. It contains an
acidic transcriptional activation domain, a nuclear locali-
zation sequence, and a DNA binding domain consisting
of 13 C2H2-type zinc fingers [7]. Zinc finger proteins
are characterized by the presence of two cysteines
(Cys2) and two histidines (His2) in what is called a zinc
finger domain. This domain stabilizes the three-dimen-
sional structure, consisting of a two-stranded antiparallel
b-sheet and an a-helix surrounding a central zinc ion
[8]. Zinc finger proteins play important roles in multiple
biological processes, gene expression, differentiation,
and embryonic development [9,10].
To explore the role of Zfx in human malignant
glioma, we began with an expression analysis of Zfx
mRNA in glioma tumors and glioma cell lines. We also
used lentivirus-mediated siRNA targeting of Zfx to
down-regulate its expression in the human malignant
cell line U251 [11]. Finally, we investigated the effect of
Zfx silencing on the cell cycle, apoptosis, and prolifera-
tion of U251 cells.
2. Materials and methods
2.1 Cell line preparation
Human glioma U251 cells, derived from grade IV astro-
cytomas-glioblastoma multiforme (GBM), and human
renal epithelial 293T cells were purchased from Cell
Bank Type Culture Collection of Chinese Academy of
Sciences (CBTCCCAS, Shanghai, China) and maintained
in Dulbecco’s modified Eagle’sm e d i u m( D M E M ,
GIBCO) with 10% fetal bovine serum (FBS, GIBCO) at
37°C in a humidified atmosphere of 5% CO2.
2.2 Clinical sample preparation
Before the study began, written informed consent was
obtained from all patients who participated in the study,
which was approved by the Ethics Committee of Soo-
Chow University. All experiments comply with the cur-
rent laws of our country. Thirty-five glioma samples
were obtained from 35 Chinese patients from March
2009 to Septemper 2010 at the Department of Neuro-
surgery of The First Affiliated Hospital of Soochow Uni-
versity (Grade I-4cases, Grade II-13cases, Grade III-
11cases, and Grade IV-7cases according to the 2007
WHO Classification system). The patients consisted of
19 males and 17 females. The mean ages of the patients
at the time of surgery were 38 (male) and 41 (female).
All tumors were from patients with newly diagnosed
gliomas, who had received no therapy before sample
collection. Five adult noncancerous brain tissues were
obtained from surgical resections of 5 trauma patients
for whom a partial resection of normal brain tissue was
required as decompression treatment to reduce
increased intracranial pressure under the permission of
each patient’s family. A portion of these surgically
removed samples was immediately snap frozen in liquid
nitrogen, and the remaining samples were fixed with
formalin and embedded in paraffin for histological
studies.
2.3 The expression of Zfx in U251 cells, U87 cells, U373
cells, and A172 cells by semi-quantitative RT-PCR
Total RNA from the 4 cell lines was extracted using Tri-
zol reagent (Invitrogen, Inc.) according to the manufac-
turer’s instructions. Briefly, 2 μg of total RNA from each
sample was reverse transcribed to single-stranded








The semi-quantitative RT-PCR comprised an initial
denaturation at 95°C for 15s, then 22 cycles at 95°C for
5s and 60°C for 30s. PCR products were run on a 2%
agarose gel.
2.4 The expression of Zfx in 35 pathologically confirmed
glioma samples and 5 noncancerous brain tissue samples
by real-time quantitative PCR
Total RNA was isolated from glioma tissue using Trizol
reagent (Invitrogen USA). cDNA was prepared from 2-6
μg of total RNA using superscript II reverse transcrip-
tase (Invitrogen USA) and random hexamer primers. 1
uL of the cDNA was used for real-time PCR, which was
performed to detect Zfx using SYBR Green Mixture
(TaKaRa, Japan) according to the manufacturer’sp r o t o -
col. Sequences of both Zfx and GAPDH primers have
been previously listed. Real-time PCR comprised an
initial denaturation at 95°C for 15s, then 45 cycles at 95°
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Page 2 of 10C for 5s and 60°C for 30s. The data were analyzed using
GraphPad PRISM4.0 Software. Results were presented
as CT values, defined as the threshold PCR cycle num-
ber at which an amplified product was first detected.
The average CT was calculated for both Zfx and
GAPDH, and ΔCT was determined as the mean of the
triplicate CT values for Zfx minus the mean of the tri-
plicate CT values for GAPDH. The 2
-ΔΔCT method was
used to analyze the relative changes in gene expression.
2.5 Lentivirus vectors for Zfx small interfering RNA
pGCL-GFP-Lentivirus was used to express small inter-
fering RNAs (siRNAs) targeting the Zfx ORF sequence
(Genbank no. NM_003410) (Zfx-siRNA lentivirus). A
non-targeting sequence was used as a lentivirus negative
control (NC) and was purchased from Shanghai Gene-
chem, Co. Ltd. The template of the experiment:5’-
GCCTGAGAATGATCATGGA-3’.
The sequences were cloned into the pGCSIL-GFP
(GeneChem, Shanghai, China) to generate the lentiviral
vectors. Human renal epithelial 293T cells were infected
with Zfx-siRNA lentivirus and NC lentivirus. The inter-
ference efficiency of the template was detected by Wes-
tern blot analysis.
2.6 Western blot analysis
Cells were harvested in RIPA buffer that was supple-
mented with protease and phosphatase inhibitor cock-
tails. Proteins were separated by SDS-PAGE, transferred
onto PVDF membranes, and stained for the following
proteins: anti-Zfx (Sigma,1:3000), anti-GAPDH (Santa-
Cruz,1:5000). Secondary antibodies conjugated to horse-
radish peroxidase and ECL Western blotting reagents
were used for detection.
2.7 U251 cells were infected with Zfx-siRNA lentivirus
Human glioma U251 cells were infected with Zfx-siRNA
lentivirus and NC lentivirus. Nontransfected cells were
also included as a control. After 3 days of infection, GFP
expression was observed by fluorescent microscopy. After
5 days of infection, cells were harvested to determine
knock-down efficiency by real-time quantitative PCR.
2.8 Cell growth assay
Cell growth was measured via multiparametric high-
content screening (HCS). Briefly, human glioma U251
cells at 10 days after being infected with either NC lenti-
virus or Zfx siRNA lentivirus were seeded at 2000 cells
per well in 96-well plates, then incubated at 37°C with
5% CO2 for 5 days. Plates were processed with the
ArrayScan™ HCS software (Cellomics Inc.) and kept at
+4°C for up to 24 h before each day’s analysis. The sys-
tem is a computerized, automated fluorescence-imaging
microscope that automatically identifies stained cells
and reports the intensity and distribution of fluores-
cence in each individual cell. Images were acquired for
each fluorescence channel, using suitable filters and 20
× objective. In each well, at least 800 cells were ana-
lyzed. Images and data were stored in a Microsoft SQL
database for easy retrieval.
2.9 BrdU incorporation assay
DNA synthesis in proliferating cells was determined by
BrdU incorporation. Cells were spread onto 96-well
plates and incubated for 24 or 48 hours. 10 uL 1 × 5-
bromodeoxyuridine (BrdU) reagent was added from 2 hr
to 24 hr, 100 uL Fixing Solution was added to the cells
for 30 min. The cells were washed with Wash Buffer
and incubated for 60 min with 50 μl 1 × BrdU antibody.
After adding 50 μl1×G o a ta n t i - M o u s eI g G ,5 0μl
TMB substrate solution was added. Following 30 min
incubation, the stop solution was added. The OD was
measured at 450 nm using a plate reader.
2.10 Flowcytometric analysis of cell cycle distribution
The cells infected with Zfx -siRNA lentivirus or NC len-
tivirus on the tenth day were plated onto six-well plates
in triplicate and incubated at 37°C for 5 days. Cells were
then collected, washed twice with ice-cold phosphate-
buffered saline (PBS), fixed with 70% ice-cold ethanol,
and stained with propidium iodide (PI, 50 μg/ml) in the
presence of RNase (100 μg/ml). 1 × 10
4 cells were ana-
lyzed for the cell cycle phase by flow cytometry.
2.11 Detection of apoptosis by flow cytometry
Cell apoptosis was assayed by staining with Annexin V-
APC and detected by flowcytometry. For analysis of
apoptosis, the cells were stained with 100 ul binding
buffer containing 5 ul Annexin V-APC at room tem-
perature in the dark for 10-15 min. Cells were analyzed
using flow cytometry. All experiments were performed
in triplicate.
2.12 Statistical analysis
One-way ANOVA and Student’st - t e s tw e r eu s e df o r
raw data analysis. Statistical analysis was performed
using the SPSS12.0 software package. All values in the
text and figures are expressed as the mean ± SD of
these observations. A value of P < 0.05 was considered
to be statistically significant.
3. Results
3.1 Measurement of Zfx mRNA in U251 cells, U87 cells,
U373 cells, and A172 cells
We detected the expression of Zfx mRNA in glioma cell
lines U251, U87, U373, and A172 by semi-quantitative
RT-PCR. Zfx mRNA was expressed in all four cell lines
(Figure 1).
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Page 3 of 103.2 The relative expression levels of Zfx mRNA in glioma
tissue samples and noncancerous brain tissue samples
In order to examine whether there is a significant differ-
ence in the expression of Zfx mRNA in glioma tissue
compared to noncancerous brain tissue, we performed
real-time quantitative PCR. Zfx mRNA is elevated in
gliomas compared to noncancerous brain tissue (Figure
2A). We identified correlation between glioma malig-
nancy and Zfx mRNA expression. However, this was
not the case for Grade III and Grade IV (Figure 2B).
3.3 The interference efficiency of the template was
detected by Western blot analysis
293T cells were infected with Zfx-siRNA lentivirus or
NC lentivirus. As shown in Figure 3, Zfx protein level
detected by Western blot was greatly reduced in Zfx-
siRNA infected cultures, indicating effective knockdown
of the target sequence.
3.4 Lentivirus-mediated knock-down of Zfx in the human
malignant cell line U251
T ob e g i nt oe x p l o r et h er o l eo fZ f x ,w ek n o c k e dd o w n
Zfx levels in the human malignant cell line U251. As
shown in Figure 4, by 3 days after infection, efficien-
cies were greater than 80% for both Zfx-siRNA lenti-
virus and NC lentivirus. There was no significant
difference between the negative control cells and the
nontransfected cells, indicating that the transfection
process itself had no effect on cell growth. Zfx mRNA
levels in U251 cells at 5 days after infection with Zfx-
siRNA lentivirus and NC lentivirus were assessed by
real-time PCR. Zfx-siRNA lentivirus infected cultures
had significantly lower levels of Zfx mRNA compared
to levels in cultures infected with NC lentivirus (Table
1a n dF i g u r e5 ) .
3.5 Knocking down Zfx in human malignant cell line
U251 slows cell growth
To explore the function of Zfx on cell growth, U251
cells expressing either Zfx -siRNA lentivirus or NC len-
tivirus were monitored by high-content screening (HCS)
Figure 1 The expression of Zfx mRNA in the four glioma cell
lines was measured by Semi-quantitative RT-PCR. The symbols
are: U251-U251 cells, U87-U87 cells, U373-U373 cells, and A172-A172
cells. A constitutively expressed Gapdh gene was used as an
internal control.
Figure 2 The expression level of Zfx mRNA in the glioma
samples and the noncancerous brain tissue detected by real-
time quantitative PCR. (a) The higher expression level of Zfx in all
glioma samples (including the Grade I to Grade IV) versus the
noncancerous brain tissue. (p = 0.01). (b) The expression level of
each grade glioma versus the noncancerous brain tissue. *P < 0.05.
Figure 3 Protein of Zfx in 293T cells measured by western blot.
Compared with NC, the level of Zfx protein in 293T cells decreased
markedly after Zfx expression was silenced by RNAi. Gapdh is a control.
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regulation of Zfx decreased the total number of cells.
U251cells expressing Zfx-siRNA lentivirus and NC lenti-
virus were seeded in 96-well plates, and cell growth was
assayed every day for 5 days (Table 2 and Figure 6B).
Cell growth rate was defined as: cell count of Nth day/
cell count of 1
st day, where n = 2,3,4,5 (Table 3 and Fig-
ure 6C). The amounts of DNA synthesized also
decreased on the 1
st and 4th day after infection with Zfx
-siRNA lentivirus (Table 4 and Figure 7). The results of
the study show that cell proliferation was significantly
inhibited over the course of 4 days. Data shown are the
Figure 4 Human malignant cell line U251 infected with Zfx-siRNA or NC lentivirus and nontransfected cells were examined by
fluorescent microscopy and light microscopy at the 3
rd day after infection. More than 80% of U251 cells expressed GFP. There was no
significant difference between the negative control group and the nontransfected group, indicating the transfection process has no effect on
cells growth. a: 200 × B; b: NC 200 × B; c: NC 200 × B; d: KD 200 × G; e: KD 200 × G. Representative images of the cultures are shown.
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formed in triplicate (n = 3, indicates P <0 . 0 5 ) .T h e s e
results indicate that knockdown of Zfx expression signif-
icantly inhibited proliferation and DNA synthesis of
human malignant cell line U251.
3.6 Knocking down of Zfx in human malignant cell line
U251 arrests the cell cycle in S phase
To determine whether Zfx is necessary for cell cycle
progression of the human malignant cell line U251, we
assessed the cell cycle phases in U251 cells by flow
cytometry (Figure 8A). The NC Group displayed the
following distribution: (G0/G1 46.95%, S 35.12%, G2/M
17.93%), and the Zfx-siRNA Group displayed the fol-
lowing: (G1 24.57%, S 62.82%, G2/M 12.61%). As
shown in Figure 8B, compared to control cultures, Zfx
-siRNA lentivirus cultures displayed a significant
increase in the percentage of cells in S phase (NC
35.12 ± 1.26% vs Zfx -siRNA 62.82 ± 3.696%, P =
0.003). A significant increase of cells in the subG1
fraction was observed in the Zfx -siRNA Group com-
pared to the NC Group (NC 0.15 ± 0.046% vs Zfx
-siRNA 5.51 ± 0.90%, P = 0.0009). (Figure 8C) Taken
together, these data suggest that Zfx regulates cell
growth and blocks cell cycle progression.
3.7 Knocking down of Zfx in human brain glioma U251
cells increase cell apoptosis
To test whether Zfx expression affects human brain
glioma U251 cell apoptosis, we knocked down Zfx in
this cell line. Cell apoptosis was determined by Annex-
inV staining and followed by flow cytometry (Figure
9A). As shown in Figure 9B, cell apoptosis was signifi-
cantly increased in the Zfx-siRNA Group compared to
Table 1 CT values of GAPDH and Zfx detected by real-
time quantitative PCR









16.34 ± 0.06 25.89 ± 0.04 1.00 ± 0.06
Zfx-
siRNA
16.1 ± 0.02 28.27 ± 0.10 0.16 ± 0.001
Table 1:CT values of GAPDH and Zfx detected by real-time quantitative PCR.
The Zfx mRNA expression levels in U251 cells at the 5
th day after infection
with Zfx-siRNA lentivirus and NC lentivirus were analyzed by 2
-△△CT method. (P
= 0.001).
Figure 5 The cells were lysed and RNAs were extracted to
examine Zfx expression levels in U251 cells at the 5
th day after
infection with Zfx-siRNA lentivirus and NC lentivirus by real-
time PCR analysis. The Zfx mRNA level decreased significantly after
zfx knockdown.
Figure 6 Effect of down-regulated Zfx on human malignant
cell line U251 growth. (A) High content cell imaging assays
were applied to acquire raw images (unprocessed by software
algorithm) of cell growth. (B) Human malignant cell line U251
expressing Zfx-siRNA lentivirus and NC lentivirus were seeded in 96-
well plates and cell growth was assayed every day for 5 days. (NC





th days by assay. (NC vs Zfx -siRNA, P < 0.05).
Table 2 Cell numbers counted by cellomics
AV/num scr-siRNA Zfx-SiRNA
day 1 1785.2 ± 86.31 1198.8 ± 53.93
day 2 2337.0 ± 102.75 1254.6 ± 78.84
day 3 2872.0 ± 78.25 1225.4 ± 59.87
day 4 3260.4 ± 75.77 1219.6 ± 56.05
day 5 3505.0 ± 126.04 1198.2 ± 71.14
Table 2:Cell numbers counted for 5 days after transfected with Zfx-siRNA
lentivirus and NC lentivirus. (The p value = 0.0079. P < 0.05).
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Page 6 of 10the NC Group (NC 4.32 ± 0.14% vs. Zfx -siRNA 15.93 ±
0.77%, P = 0.001). These results indicate that Zfx
expression is a determinant of human brain glioma
U251 cell apoptosis.
4. Discussion
Recent research shows that Zfx is important for
tumorigenesis. Zfx plays a pivotal role in embryonic
stem cells and in hematopoietic stem cells. A recent
study by Galan Caridad and his colleagues [12] showed
that Zfx, is a shared transcriptional regulator of ESC
and HSC, suggesting a common genetic basis of self-
renewal in embryonic and adult stem cells. Previous
work by Gang Hu et al[13] based on a genome-wide
siRNA screen in mouse embryonic stem cells found
148 genes whose down-regulation caused differentia-
tion. The study further discovered that a unique mod-
ule in the self-renewal transcription network is formed
by Cnot3, Trim28, c-Myc, and Zfx. The transcriptional
targets of this module are enriched for genes involved
in cell cycle, cell death, and cancer, and may represent
novel anti-cancer targets. Recently, Arenzana et al also
reported that Zfx is a novel transcriptional regulator of
the B-cell lineage, and one of the common genetic
control genes of both stem cell maintenance and lym-
phocyte homeostasis [14]. The present study discov-
ered that Zfx expression is significantly higher in both
Follicular Lymphoma (FL) and Diffuse large B cell lym-
phoma (DLBCL) and may be used for prognostic pur-
poses in the clinic [15]. Huang D [16] and others
found that stem cell-related genes (including OCT-4,
SOX-2, BMI-1, and ZFX) were upregulated in SP(side
population) cells of human esophageal carcinoma 9706
cells compared with non-SP cells.
To date, most research has focused on the expression
and function of Zfx in embryonic stem cells and hema-
topoietic stem cells. In oncology researches, studies dis-
covered that Zfx is abnormally expressed in prostate
cancer, breast cancer, and leukemia [15]. However, its
expression and function in human glioma had not been
studied. Thus, we first explored the expression levels of
Zfx mRNA in four glioma cell lines and found that it
was expressed in all of them. We then detected the
expression level of Zfx mRNA in glioma samples and in
noncancerous brain tissue. Zfx was more highly
expressed in glioma samples than in noncancerous brain
t i s s u eT os o m ee x t e n t ,w ea l s of o u n dt h a tZ f xe x p r e s -
sion increased with increasing tumor grade (however,
this was not true for Grades III or IV). This may be due
to the fact that Zfx mutations may occur at high fre-
quency in high grade malignant gliomas. In order to
assess Zfx function in glioma cell lines, we infected
human glioblastoma U251 cells with Zfx-siRNA lenti-
virus or control lentivirus. Compared to controls, Zfx-
siRNA treated cells showed decreased proliferation,
increased apoptosis, and an increase in the proportion
of cells in S and subG1 phases. Thus, Zfx promotes
U251 cell growth.
Our data suggest that Zfx may be related to cell cycle
checkpoints in U251 cells. The cell has developed a ser-
ies of checkpoints to ensure quality control over prolif-
eration. In particular, S phase represents a critical
period for cells to commit to proliferation or undergo
growth arrest [17]. Understanding the regulation of the
S phase transition is central to the study of many dis-
eases, particularly cancer [18,19]. The cell cycle is a well
regulated process that depends on the combined action
of both cell cycle activators and inhibitors [20].
With the emergence of the cancer stem cell theory,
many researchers now believe that glioma stem cells
Table 3 Cell growth rate counted by cellomics
AV/fold scr-siRNA Zfx-SiRNA
day 1 1.00 ± 0.00 1.00 ± 0.00
day 2 1.31 ± 0.01 1.05 ± 0.02
day 3 1.61 ± 0.05 1.02 ± 0.02
day 4 1.83 ± 0.07 1.02 ± 0.01
day 5 1.96 ± 0.04 1.00 ± 0.02




th day after transfection
with Zfx-siRNA lentivirus and NC lentivirus.
Table 4 The amounts of DNA synthesized detected by
BrdU incorporation assay
ODBrdu day 1 day 4
scr-siRNA 0.257 ± 0.024 0.651 ± 0.039
Zfx-siRNA 0.126 ± 0.006 0.146 ± 0.005
p value 0.0082 0.0017
Table 4: The amount of DNA synthesized was analyzed by BrdU incorporation
on the 4
th day and 1
st day. (NC vs Zfx -siRNA,P < 0.05).
Figure 7 Down-regulated Zfx in human malignant cell line
U251 displayed changes in DNA synthesis. The DNA synthesis
rate was analyzed by BrdU incorporation assay on the 1
st and 4
th
days. (NC vs Zfx -siRNA, P < 0.05).
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Page 7 of 10Figure 8 Knocking down Zfx in human malignant cell line U251 arrested the cell cycle. Knockdown of Zfx expression induced S arrest
in U251 cells. (A) Cell cycle of U251 cells was analyzed by flow cytometry. (B) S cell cycle phase determined by flow cytometry. Compared with
NC, Zfx-siRNA cultures showed a significant increase in cells in S (P = 0.003; P < 0.05), compared with NC. (C) Percentage of apoptosis was
plotted against U251 cell line. There was a greater amount of apoptosis in the Zfx down-regulated group of human brain glioma U251 cells (P =
0.0009, P < 0.05). The assay showed a marked induction of apoptosis with 5.51% apoptotic for NC group.
Zhou et al. Journal of Experimental & Clinical Cancer Research 2011, 30:114
http://www.jeccr.com/content/30/1/114
Page 8 of 10a r ea tt h er o o to fd i s e a s er e c u r r e n c ed u ei nl a r g ep a r t
to their natural drug resistance and insensitivity to
radiation therapy, Thus, successful tumor treatment
likely depends on complete eradication of tumor stem
cells [21]. Cancer stem cells with self-renewal capabil-
ity can constitute a tumor by proliferation and differ-
entiation, key processes in the formation,
proliferation, and invasiveness of cancer [22,23]. Zfx
may be a key gene involved in the molecular basis of
stem cells, and this also potentially implicates it in
cancer stem cell biology. However, whether Zfx plays
a role in glioma stem cell self-renewal growth is cur-
rently unknown.
In summary, our study highlights critical roles for
Zfx in the human malignant glioma cell line U251.
This study may provide the basis for further explora-
tion of the role of Zfx in the occurrence and develop-
ment of human glioma. We will continue to work on
Figure 9 Knock down of Zfx in human malignant cell line U251 increased cell apoptosis. (A) Cell death was determined by Annexin V
staining and flow cytometry. (B) Zfx-siRNA cultures showed a significant increase in apoptosis compared with NC (P = 0.001; P < 0.05).
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Page 9 of 10the mechanism by which Zfx influences glioma cell
biology.
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